The effect of the Buteyko breathing technique on asthma control and quality of life in children with asthma aged 7-12 years: a randomized controlled study [0.03%]
布特亚科呼吸法对哮喘儿童（7至12岁）的哮喘控制及生活质量的影响：一项随机对照研究
Hakan Çelik,Emel Yuruk
Hakan Çelik
Thirty-three participants were assigned to the experimental group in which Buteyko breathing technique was applied in addition to standard asthma treatment and 32 participants were assigned to the control group in which standard asthma treatment was applied.
Clinical Trial
PeerJ. 2025 Jun 3:13:e19467. DOI:10.7717/peerj.19467 2025
Advancements in Biologic Therapies for Pediatric Asthma: Emerging Therapies and Future Directions [0.03%]
儿科哮喘生物制剂治疗新进展：新兴疗法和未来方向
Pablo Xavier Anda Suárez,Uziel Márquez Romero,Nayely García Méndez et al.
Pablo Xavier Anda Suárez et al.
In conclusion, the advancement in biologic therapies is offering significant progress for personalized severe asthma treatment among pediatrics, especially for the T2-high endotype.
[Research progress on the relationship between gut microbiota and childhood bronchial asthma] [0.03%]
肠道菌群与儿童支气管哮喘关系的研究进展
Lei Yu,Mao-Lan Wu,Xiang-Rong Zheng
Lei Yu
Furthermore, the potential value and application prospects of modulating gut microbiota as a new strategy for asthma treatment are discussed, providing a theoretical reference for in-depth research on the relationship between gut microbiota and the onset of childhood asthma and the development of new
Sarah L Rhoads,Lior Seluk,Michael E Wechsler
Sarah L Rhoads
In the last few decades, asthma treatment paradigms have transformed from recommendations to use anti-inflammatory and bronchodilatory inhalation-based therapies including corticosteroids and beta-agonists, to more precisely targeted add-on biologic therapies that employ monoclonal antibodies addressing
The dilemma of the asthmatic patient: fight with the help of drugs or escape to a healthier environment? [0.03%]
哮喘病患者的两难选择：借助药物战斗还是寻找更健康的生活环境？
Giovanni Rolla
Giovanni Rolla
Greater consideration of the environmental triggers of asthma exacerbations can help the clinician further personalize the asthma treatment strategy.
Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma [0.03%]
杜匹鲁单抗治疗重度哮喘的哥伦比亚患者队列的有效性现实世界证据
Abraham Alí-Munive,Josefina Zakzuk,Nelson J Alvis-Zakzuk et al.
Abraham Alí-Munive et al.
Background: Real-world effectiveness and safety of dupilumab for asthma treatment have been evaluated in USA and Europe, but research from Latin America is lacking.
Isochlorogenic Acid C Alleviates Allergic Asthma via Interactions Between Its Bioactive Form and the Gut Microbiome [0.03%]
异氯ogenic酸C通过其生物活性形式及其与肠道微生物组的相互作用来缓解过敏性哮喘
Jing-Yi Xu,Xiao-Juan Rong,Zhen Shen et al.
Jing-Yi Xu et al.
This study not only provides a solid foundation for the potential clinical use of ICGAC in asthma treatment but also offers novel insights for future research and therapeutic strategies targeting asthma.
Impact of the COVID-19 Pandemic on Lung Function and Treatment Decisions in Children with Asthma: A Retrospective Study [0.03%]
新冠肺炎大流行对哮喘儿童肺功能和治疗决策影响的回顾性研究
Jaqueline Abdul-Razzak,Mihaela Ionescu,Radu Diaconu et al.
Jaqueline Abdul-Razzak et al.
Conclusions: During epidemiological circumstances, a strong collaboration between the parents/caregivers/pediatric patients with asthma and attending physicians is essential to correctly assess the symptoms and to comply the asthma treatment with ICS and a bronchodilator in order to control the disease
Yangke powder alleviates OVA-induced allergic asthma by inhibiting the PI3K/AKT/NF-κB signaling pathway [0.03%]
洋金花粉通过抑制PI3K/AKT/NF-κB信号通路缓解卵清蛋白致敏的小鼠哮喘症状
Xueyan Li,Lu Ding,Zirui Li et al.
Xueyan Li et al.
Methods: We employed UPLC-Q-Exactive Orbitrap-MS to analyze YKS constituents, identified key ingredients, and explored asthma treatment mechanisms through bioinformatics, network pharmacology, Mendelian randomization, and molecular docking.
Application of Biologics in the Treatment of Asthma in the Past Two Decades: A Bibliometric Analysis and Beyond [0.03%]
生物制剂治疗哮喘二十年的文献计量分析及展望
Zicong Zhou,Xiaoying Chen,Shixiu Liang et al.
Zicong Zhou et al.
This study aims to demonstrate the bibliometric characteristics of articles on biologics for asthma treatment over the past two decades. There were 3395 articles published in 653 journals from 91 countries/regions from January 1, 2000 to September 30, 2023.
耗时 0.20926 秒，为您在
48206918
条记录里面共找到 1856 篇文章 [XML]